Recent Finacing
Recent Raise
Actimed Therapeutics is a London-based clinical-stage biopharmaceutical developing S‑pindolol benzoate (ACM‑001) for cancer cachexia, advancing PK/PD studies and Phase 2b/3 IMPACT trials in NSCLC and CRC.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Actimed Therapeutics.
